投稿信模版一来源：XX (Editor):Here is our paper submitted to "(XX Journal)".The Title: XXXXThe Authors: XXX XXX and XXXIn this paper, we ...The authors claim that none of the material in the paper has been published or is under consideration for publication elsewhere.The corresponding author is Dr. XXX and his address and other information is as following:Address: Department of XXX, XX University, ...,Tel: +86-xxx-xxxxxxxxFax: +86-xxx-xxxxxxxxThank you very much for consideration!Sincerely Yours,Dr. xxx投稿信模版二来源：Prof. XXXXX,Here within enclosed is our paper for consideration to be published on "(Journal name)". The further information about the paper is in the following:The Title: XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXThe Authors: XXXXX XXXXX and XXXXXThe authors claim that none of the material in the paper has been published or is under consideration for publication elsewhere.I am the corresponding author and my address and other information is as follows, Address: Department of XXXXXXXXX, Tsinghua University,Beijing, 10084,Tel: 86-Fax: 86-Thank you very much for consideration!Sincerely Yours,Dr. XXXXXXXXXXX投稿信模版三来源：（1）Dear Mr. **1. The work described has not been submitted elsewhere for publication, in whole orin part, and all the authors listed have approved the manuscript that is enclosed.2. I have read and have abided by the statement of ethical standards for manuscripts submitted to Neuroscience.kind regards.Your sincerely,通讯作者（2）Dear Dr. 主编name:We submit our manuscript entitled " 文章title" to 杂志名for publication.接着简单介绍你文章的主要创新点和意义，不易过多，但要突出新意和关键点。

All authors have seen the manuscript and approved to submit to your journal. Thank you very much for your attention and consideration.Sincerely yours,通讯作者（3）Dear Dr. 主编name:We submit our manuscript entitled " 文章title" to 杂志名for publication.接着简单介绍你文章的主要创新点和意义，不易过多，但要突出新意和关键点。

All authors have seen the manuscript and approved to submit to your journal. Thank you very much for your attention and consideration.Sincerely yours,通讯作者（4）Dr. ***Editor-in-Chief, ***(add address) January 22, 2003Dear Dr. **,Enclosed herewith please find 3 copies of a MS by: ‘***. *** and ***’ entitled: “**********”, which we would like to submit for publication in the ‘******'. Looking forward to your decision,With kind personal regards,Sincerely yours,（5）Dear Prof. Gil:This is a manuscript by**and **entitled “.......”. It is submitted to be considered forpublication as a “...” in your journal. This paper is new. Neit her the entire paper nor any part of its content has been published or has been accepted elsewhere. It is not being submitted to any other journal.We believe the paper may be of particular interest to the readers of your journal as it ........Correspondence should be addressed to **at the following address, phone and fax number, and email address:...Thanks very much for your attention to our paper.Sincerely yours,**投稿信模版四（实例）来源：1Dear Editor,We would like to submit the enclosed manuscript entitled "GDNF Acutely Modulates Neuronal Excitability and A-type Potassium Channels in Midbrain Dopaminergic Neurons", which we wish to be considered for publication in Nature Neuroscience.GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinson’s disease. In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices. Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase. Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF. Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release. These results may also have implications in the treatment of Parkinson’s disease.Due to a direct competition and conflict of interest, we request that Drs. XXX of Harvard Univ., and YY of Yale Univ. not be considered as reviewers. With thanks for your consideration, I amSincerely yours,case2Dear Editor,We would like to submit the enclosed manuscript entitled "Ca2+-binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release", which we wish to be considered for publication in Neuron.We believe that two aspects of this manuscript will make it interesting to general readers of Neuron.First, we report that GDNF has a long-term regulatory effect on neurotransmitter release at the neuromuscular synapses. This provides the first physiological evidence for a role of this new family of neurotrophic factors in functional synaptic transmission. Second, we show that the GDNF effect is mediated by enhancing the expression of the Ca2+-binding protein frequenin. Further, GDNF and frequenin facilitate synaptic transmission by enhancing Ca2+ channel activity, leading to an enhancement of Ca2+ influx. Thus, this study has identified, for the first time, a molecular target that mediates the long-term, synaptic action of a neurotrophic factor. Our findings may also have general implications in the cell biology of neurotransmitter release.[0630][投稿写作]某杂志给出的标准Sample Cover Letter[the example used is the IJEB]Case 3Sample Cover Letter[the example used is the IJEB]Dear Editor of the [please type in journal title or acronym]:Enclosed is a paper, entitled "Mobile Agents for Network Management." Please accept it as a candidate for publication in the [journal title]. Below are our responses to your submission requirements.1. Title and the central theme of the article.Paper title: "Mobile Agents for Network Management." This study reviews the concepts of mobile agents and distributed network management system. It proposes a mobile agent-based implementation framework and creates a prototype system to demonstrate the superior performance of a mobile agent-based network over the conventional client-server architecture in a large network environment.2. Which subject/theme of the Journal the material fitsNew enabling technologies (if no matching subject/theme, enter 'Subject highly related to [subject of journal] but not listed by [please type in journal title or acronym])3. Why the material is important in its field and why the material should be published in [please type in journal title or acronym]The necessity of having an effective computer network is rapidly growing alongside the implementation of information technology. Finding an appropriate network management systemhas become increasingly important today's distributed environment. However, the conventional centralized architecture, which routinely requests the status information of local units by the centralserver, is not sufficient to manage the growing requests. Recently, a new framework that uses mobile agent technology to assist the distributed management has emerged. The mobile agent reduces network traffic, distributes management tasks, and improves operational performance. Given today's bandwidth demand over the Internet, it is important for the [journal title/acronym] readersto understand this technology and its benefits. This study gives a real-life example of how to use mobile agents for distributed network management. It is the first in the literature that reports the analysis of network performance based on an operational prototype of mobile agent-based distributednetwork. We strongly believe the contribution of this study warrants its publication in the [journal title/acronym].4. Names, addresses, and email addresses of four expert referees.Prof. Dr. William GatesChair Professor of Information Technology321 Johnson HallPremier University Lancaster, NY 00012-6666, USAphone: +8 - fax: +6 e-mail:Expertise: published a related paper ("TCP/IP and OSI: Four Strategies for Interconnection") in CACM, 38(3), pp. 188-198.Relationship: I met Dr. Gate only once at a conference in 1999. I didn't know him personally.Assoc Prof. Dr. John AdamsDirector of Network Research CenterCollege of Business Australian University123, Harbor Drive Sydney,Australia 56789phone: +6 - fax: +6e-mail:Expertise: published a related paper ("Creating Mobile Agents") in IEEE TOSE, 18(8), pp. 88-98. Relationship: None. I have never met Dr. Adams.Assoc Prof. Dr. Chia-Ho ChenChair of MIS DepartmentCollege of ManagementOpen University888, Putong RoadKeelung, Taiwan 100phone: +886-2-8888-8888 - fax: +886-2-8888-8886e-mail:Expertise: published a related paper ("Network Management for E-Commerce") in IJ Electronic Business, 1(4), pp. 18-28.Relationship: Former professor, dissertation chairman.Mr. Frank YoungPartner, ABC Consulting888, Seashore HighwayWon Kok, KowloonHong Kongphone: +852-8888-8888 - fax: +852-8888-8886e-mail:Expertise: Mr. Young provides consulting services extensively to his clients regarding network management practices.Relationship: I have worked with Mr. Young in several consulting projects in the past three years.Finally, this paper is our original unpublished work and it has not been submitted to any other journal for reviews.Sincerely,Johnny Smith投稿信模版五来源：Editor,Herewith we are very pleased to submit a manuscript entitled above to you for your kind considereation for publication in XXX(杂志名). We ensure you that this Ms has not been submitted elsewhere for consideration of publication.Thank you.Sincerely YoursXXX投稿信模版六来源：473-1-1 Dr．：Enclosed are three copies of a manuscript by Rose N ．Dipaola，Donna A．Gallo，and Tom N．Roberts titled“Hepatitis C Virus Infection in Long-Term TransfusionPatients”．It is submitted to be considered for publication as a“OriginalArticle" in your journal．This paper is～•Neither the entire papernor any part of its content has been published or has been accepted elsewhere．It is not being submitted to any other journal．We believe the paper may be of particular interest to the readers of yourjournal because the study it reports stated the HCV infection rate amonglong-term transfusion patients is higher than that of the general populationand of short-term transfusion patients．Correspondence and phone calls about the paper should be directed to RoseN．Dipaola at the following address，phone and fax number，and e-mail address：Rose N ．Dipaola，MDInstitute of Internal MedicineCleveland Clinic Foundation9500 Euclid Ave．Cleveland，OH44195，USATel：0Fax：0E-mail：dipao＠cesmtp ．ccf. OrgThanks very much for your attention to our paper．Sincerely yours，Rose N．Dipaola。